A clinical analysis of cancer of the base of the tongue

Abstract

Twenty-two patients (18 males, 4 females) with cancer of the base of the tongue were treated at Kyushu University Hospital during 2004–2011. They were classified by T classification as one case with T1, 8 with T2, 7 with T3, and 6 with T4a. The 3-year survival rates were 75.4% for all patients. The 3-year survival rate was 83.3% for patients treated with superselective intra-arterial chemotherapy with CDDP and DOC and irradiation, and was 71.8% for patients treated with chemotherapy with S-1 or systemic chemotherapy and irradiation.